Dr. Esmond FONG obtained his medical degree from the University of Hong Kong. He completed his residency in internal medicine, fellowship in general and interventional cardiology at Queen Elizabeth Hospital, Hong Kong. He subsequently obtained his fellowship in peripheral intervention at Massachusetts General Hospital, Harvard Medical School in Boston, US. He is currently an Associate Consultant at Queen Elizabeth hospital. His clinical interests include CHIP/ complex coronary interventions, Interventions in peripheral vascular disease, pulmonary embolism and venous diseases, heart failure management. He is currently the physician-in-charge for peripheral intervention and heart failure program at Queen Elizabeth Hospital.

Abstract:

Venous thromboembolism (VTE), which includes deep vein thrombosis and pulmonary embolism, poses a significant health risk, particularly for elderly patients. The elderly are at higher risk due to factors such as reduced mobility, pre-existing medical conditions, and acute illnesses that arise during hospitalization. VTE in this age group is linked to elevated mortality rates, more severe initial presentations, and difficulties in diagnosing pulmonary embolism.
This lecture will focus on key aspects of VTE management in the elderly, emphasizing the importance of primary prevention strategies, including the use of Direct Oral Anticoagulants (DOACs) for VTE treatment. This lecture will review the evidence supporting the use of DOACs, discuss special considerations such as renal impairment, frailty, and bleeding risk, and explore how these factors influence treatment decisions. The session will also cover recent guidelines, emerging therapeutic options, and strategies to improve adherence and safety in this vulnerable population. By the end of the lecture, attendees will gain practical insights into personalized VTE management, enhancing patient outcomes while minimizing complications in elderly patients.